Effect of the ERCC1 (C118T) Polymorphism on Treatment Response in Advanced Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy

For advanced non-small-cell lung cancer (NSCLC) cases, a platinum-based regimen is the first-line chemotherapy treatment. The excision repair cross-complementing group 1 (ERCC1) plays an important role in DNA repair and has been related to resistance to platinum chemotherapy. This study aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaewbubpa, Walennee, Areepium, Nutthada, Sriuranpong, Virote
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454696/
https://www.ncbi.nlm.nih.gov/pubmed/28032496
http://dx.doi.org/10.22034/APJCP.2016.17.11.4917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454696/
https://www.ncbi.nlm.nih.gov/pubmed/28032496
http://dx.doi.org/10.22034/APJCP.2016.17.11.4917

Ejemplares similares